CAC Holdings Corporation (TYO:4725)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,748	28,217	29,642	24,350	24,499	24,016
Market Cap Growth	5.66%	-4.81%	21.74%	-0.61%	2.01%	-7.33%
Enterprise Value	27,359	20,388	21,495	15,246	15,345	19,123
Last Close Price	2093.00	1611.67	1612.26	1268.62	1233.25	1161.50
PE Ratio	13.58	9.11	11.99	11.63	9.90	14.39
Forward PE	-	10.85	10.85	10.85	10.85	10.85
PS Ratio	0.68	0.54	0.59	0.51	0.51	0.50
PB Ratio	1.04	0.75	0.92	0.83	0.78	0.92
P/TBV Ratio	1.20	0.85	0.99	0.91	0.84	1.02
P/FCF Ratio	-	5.06	269.48	9.65	8.94	25.44
P/OCF Ratio	-	4.94	49.90	9.28	8.44	21.64
EV/Sales Ratio	0.52	0.39	0.43	0.32	0.32	0.39
EV/EBITDA Ratio	6.21	4.74	5.34	3.85	3.48	7.02
EV/EBIT Ratio	7.93	6.01	6.46	4.78	4.15	9.81
EV/FCF Ratio	-	3.66	195.41	6.05	5.60	20.26
Debt / Equity Ratio	0.05	0.06	0.08	0.10	0.10	0.12
Debt / EBITDA Ratio	0.41	0.48	0.66	0.75	0.69	1.13
Debt / FCF Ratio	-	0.37	24.03	1.17	1.11	3.25
Asset Turnover	1.05	1.01	1.09	1.05	1.04	1.08
Inventory Turnover	171.25	102.64	105.24	95.84	43.87	35.74
Quick Ratio	2.35	2.22	1.81	2.47	2.24	1.94
Current Ratio	2.60	2.41	2.02	2.69	2.46	2.27
Return on Equity (ROE)	8.43%	9.32%	8.67%	7.10%	8.71%	6.62%
Return on Assets (ROA)	4.25%	4.11%	4.49%	4.35%	5.03%	2.70%
Return on Capital (ROIC)	5.72%	5.68%	6.19%	5.97%	7.25%	4.14%
Return on Capital Employed (ROCE)	8.60%	7.70%	9.30%	9.10%	9.60%	5.70%
Earnings Yield	7.37%	10.97%	8.34%	8.60%	10.11%	6.95%
FCF Yield	-	19.77%	0.37%	10.36%	11.19%	3.93%
Dividend Yield	4.79%	5.58%	4.96%	4.73%	4.87%	5.17%
Payout Ratio	-	45.19%	48.00%	48.73%	40.59%	54.34%
Buyback Yield / Dilution	-0.21%	-0.22%	-0.54%	-0.39%	-1.66%	6.13%
Total Shareholder Return	4.57%	5.37%	4.43%	4.34%	3.21%	11.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.